# US 2012/0269888 A1 · Barrier composition

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0269888 A1
- Document ID: US20120269888A1
- Status: Published application
- Kind: A1
- Application number: 13/503,068
- Filed: 2010-10-20
- Published: 2012-10-25
- Earliest claimed: 2009-10-20
- Assignees: Nederlandse Organisatie voor toegepast-natuurwetenschappelijk onderzoek TNO
- Inventors: Jan Matthijs Jetten; Jacobus Eversdijk; Kjeld Jacobus Cornelis van Bommel; Johannes Wilhelmus Timmermans; Aafke Tessa ten Cate; Theodoor Maximiliaan Slaghek
- Web page: https://patentgrep.com/patent/US20120269888A1

## CPC

- A61K 47/38: Cellulose; Derivatives thereof
- A23P 10/35: with oils, lipids, monoglycerides or diglycerides
- A61K 9/167: {with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface (with further drug-free outer coating A61K9/5073)}
- A61K 9/1676: {having a drug-free core with discrete complete coating layer containing drug (adsorbates of liquid drug formulations on inert powders without simultaneous granulation step A61K9/141; with further drug-free outer coating A61K9/5078; drug conjugated to non-active particles A61K47/6921)}
- A61K 9/1682: {Processes}
- A61K 9/5036: {Polysaccharides, e.g. gums, alginate; Cyclodextrin}
- A61K 9/5042: {Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose}
- A61K 9/5052: {Proteins, e.g. albumin}
- A61K 9/5073: {having two or more different coatings optionally including drug-containing subcoatings}
- A61K 9/5078: {with drug-free core}
- A61K 9/5089: {Processes}
- A61K 9/5115: {Inorganic compounds}
- A61K 9/5123: {Organic compounds, e.g. fats, sugars}
- A61K 9/513: {Organic macromolecular compounds; Dendrimers}
- A61K 9/5192: {Processes}
- A61K 9/7007: {Drug-containing films, membranes or sheets (A61K9/0041, A61K9/0043, A61K9/006, A61K9/0063 take precedence)}
- A61K 47/36: Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K 47/42: Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein (oligopeptides having up to five amino acids {A61K47/183}; polyamino acids A61K47/34)
- A61P 1/14: Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A61P 3/02: Nutrients, e.g. vitamins, minerals
- B01J 13/02: Making microcapsules or microballoons {(for medical preparations A61K9/50)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23P: SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS

## Abstract

The invention is directed to a barrier composition, to a vehicle comprising said barrier composition, to a layer comprising said barrier composition, to a foodstuff comprising said vehicle or layer, to a pharmaceutical or nutraceutical composition comprising said vehicle or layer, to a method for protecting one or more active ingredients, and to the use of said barrier composition. The barrier composition of the invention comprises: a hydrophobic organic phase; and 0.1-75 vol. %, based on the total volume of the barrier composition, of biodegradable solid plate-like particles.

## Claims

### Claim 1

Barrier composition, comprising:
a hydrophobic organic phase; and
0.1-75 vol. %, based on the total volume of the barrier composition, of biodegradable solid plate-like particles.

### Claim 2 (depends on 1)

Barrier composition according to claim 1, wherein said hydrophobic organic phase comprises one or more selected from the group consisting of proteins, fatty acids, monoglycerides, diglycerides, triglycerides, phospholipids, waxes, natural resins, polysaccharides, and biodegradable polymers.

### Claim 3 (depends on 1)

Barrier composition according to claim 1, wherein said hydrophobic phase comprises
one or more biodegradable polymers; and/or
one or more hydrophobic components having at least one carboxyl group and/or ester group.

### Claim 4 (depends on 1)

Barrier composition according to claim 1, wherein said hydrophobic phase comprises
one or more hydrophobic plant storage proteins; and
one or more hydrophobic components with at least one fatty acid group.

### Claim 5 (depends on 1)

Barrier composition according to claim 1, wherein said hydrophobic phase comprises one or more zeins.

### Claim 6 (depends on 1)

Barrier composition according to claim 1, wherein said biodegradable solid plate-like particles comprise one or more selected from the group consisting of organic salts, inorganic salts, biopolymer crystals, crystalline saccharides, and layered double hydroxides, preferably one or more selected from the group consisting of calcium citrate, calcium lactate, calcium carbonate, magnesium phosphate, hydrotalcite, hydroxyapatite, amylose and cellulose.

### Claim 7 (depends on 1)

Barrier composition according to claim 1, wherein the weight ratio between the hydrophobic phase and the biodegradable solid particles in the barrier composition is in the range of 1:99 to 99:1 preferably in the range of 2:1 to 15:1.

### Claim 8 (depends on 1)

Barrier composition according to claim 1, wherein said biodegradable solid plate-like particles have an average particle size as measured by transmission electron microscopy of 50-5000 nm, preferably 100-1000 nm, more preferably 100-500 nm.

### Claim 9 (depends on 1)

Barrier composition according to claim 1, wherein said biodegradable solid plate-like particles have a plate-like form defined by an aspect ratio between the longest edge dimension of the crystal and the crystal thickness of 1.5:1 to 5000:1, preferably 5:1 to 2000:1 and most preferably from 10:1 to 1000:1.

### Claim 10 (depends on 1)

Barrier composition according to claim 1, wherein said biodegradable solid plate-like particles comprise a crystalline and/or semicrystalline phase.

### Claim 11 (depends on 1)

Barrier composition according to claim 1, wherein said composition further comprises one or more additives selected from plasticisers, antioxidants, amino acid residues, phospholipids, sugars, cross-linking agents, and colorants.

### Claim 12 (depends on 1)

Layer comprising a barrier composition according to claim 1.

### Claim 13 (depends on 1)

Method for preparing a vehicle wherein one or more active ingredients are protected from oxygen and/or water, comprising encapsulating said one or more active ingredients in a barrier composition according to claim 1.

### Claim 14 (depends on 13)

Method according to claim 13, comprising spray drying, spray cooling, spray chilling, or spray freeze drying the barrier composition together with said one or more active ingredients.

### Claim 15 (depends on 1)

Vehicle comprising one or more active ingredients and a barrier composition according to claim 1 said one or more active ingredients preferably selected from the group consisting of anti-oxidants, probiotics, vitamins, peptides, and unsaturated fatty acids, amino acids, metal ions.

### Claim 16 (depends on 15)

Vehicle according to claim 15 in the form of a core-shell capsule, wherein said shell comprises said barrier composition and said core comprises said one or more active ingredients.

### Claim 17 (depends on 11)

Foodstuff comprising a layer according to claim 11.

### Claim 18

Pharmaceutical or nutraceutical composition, comprising a layer according to claim .

### Claim 19 (depends on 1)

Use of a barrier composition according to claim 1 as a barrier against oxygen and/or water.
